REGN20934
R20934-OB-2561
Phase 1 small_molecule active
Quick answer
REGN20934 for Overweight or Obesity is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Overweight or Obesity
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active